CAS number：1384984-18-2 molecular formula：C21H25FN6O3
SPR719 (VXc-486) is a gyrase B inhibitor, with bactericidal activity. SPR719 potently inhibits multiple agent-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis , with MICs of 0.03 to 0.30 μg/ml and 0.08 to 5.48 μg/ml, respectively Form:Solid IC50& Target:gyrase B
| Chinese alias | - | ||
| English alias | GLXC-26894 | SPR719 | SPR-719 | BDBM50393079 | N-Ethyl-N'-(6-fluoro-5-(2-(1-hydroxy-1-methylethyl)-5-pyrimidinyl)-7-((2R)-tetrahydro-2-furanyl)-1H-benzimidazol-2-yl)urea | 1384984-18-2 | SCHEMBL10319524 | VXc-486 | 0O34AIS1YE | HY-12930 | MS-27581 | (R)-1 | ||
| CAS number | 1384984-18-2 | molecular formula | C21H25FN6O3 |
| molecular weight | 428.46 g/mol | Exact mass | ≥99% |
| PSA | 125.000 Ų | logp | 1.100 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
